These companies have leveraged support from the Science Center to move their ideas out of the lab and into the marketplace where they can transform our world.
Participating in QED was an eye-opening introduction to the business world for the Shihs. As Dr. Wan Shih puts it, “the business support and connections to the broader business network we received from QED were instrumental to commercializing our invention.”
Avid has expanded its footprint from a single lab in the Port incubator to custom office and lab space nearly five times that size. Acquired by Eli Lilly & Company in 2010 in a deal worth up to $800 million, Avid now operates as a wholly-owned subsidiary of the global pharmaceutical company.
As Adaptimmune’s initial landing place, the Science Center played a key role in the company’s trajectory of growth. When Adaptimmune outgrew its space at the Port business incubator, it chose to remain in Philadelphia - a sure sign of the region’s healthy bioscience sector.
Situated within an ecosystem of scientists, engineers, and entrepreneurs, Invisible Sentinel regards their Science Center location among University City’s pool of talent and mentors as “the epicenter of biotechnology in the Philadelphia region."